The weekly litigation news digest is live. Subscribe now

IP Verse

Enteric Coated, Low-Strength Pancrelipase Formulations - EP2818160

The patent EP2818160 was granted to Allergan Pharmaceuticals on Nov 8, 2017. The application was filed on Sep 30, 2011 under application number EP14176579A. The patent is currently recorded with a legal status of "Revoked".

EP2818160

ALLERGAN PHARMACEUTICALS
Application Number
EP14176579A
Filing Date
Sep 30, 2011
Status
Revoked
Jul 14, 2023
Publication Date
Nov 8, 2017
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
MATHYS & SQUIREAug 8, 2018MATHYS & SQUIREADMISSIBLE

Patent Citations (18) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS2001046493
DESCRIPTIONUS2004057944
DESCRIPTIONUS6051220
DESCRIPTIONUS7658918
DESCRIPTIONWO2006044529
OPPOSITIONCA2263703
OPPOSITIONCN101249081
OPPOSITIONEP1967211
OPPOSITIONUS2008187525
OPPOSITIONUS2012201875
OPPOSITIONUS5578304
OPPOSITIONUS5750104
OPPOSITIONWO2007020259
OPPOSITIONWO2008017659
OPPOSITIONWO2009083607
OPPOSITIONWO2010025126
SEARCHEP1579771
SEARCHUS7658918

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents